मैगज़्टर गोल्ड के साथ असीमित हो जाओ
10,000 से अधिक पत्रिकाओं, समाचार पत्रों और प्रीमियम कहानियों तक असीमित पहुंच प्राप्त करें सिर्फ
कोशिश गोल्ड - मुक्त
PLI boost: Cancer drugs to cost less
Mint Mumbai
|March 05, 2025
Cancer patients facing prohibitive treatment costs in India can hope for relief.
The nation's top drugmakers have started manufacturing key medicines for such diseases in the country.
India's largest drugmaker Sun Pharmaceutical Industries Ltd and its peers Cipla Ltd, Glenmark Pharmaceuticals Ltd, Cadila Healthcare Ltd and Biocon Ltd are making cancer drugs under the production-linked incentive (PLI) scheme, according to information shared by the department of pharmaceuticals with Mint. They are among the 55 companies selected for incentives to produce 175 high-value medicines in India.
At present, most cancer drugs are imported, making them prohibitively expensive. That's when India's cancer burden is expected to rise from 26.7 million life years or DALYS-the sum of healthy life lost to a disease-in 2021 to 29.8 million in 2025, according to data from the Indian Council of Medical Research (ICMR).
यह कहानी Mint Mumbai के March 05, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Mumbai से और कहानियाँ
Mint Mumbai
Paint firms strengthen moats as competition heats up
A bruising market-share battle is escalating in India's ₹70,000-crore paints sector, forcing companies to look beyond aggressive discounting and instead strengthen their foothold in key geographical areas while sharpening their product portfolios.
2 mins
November 28, 2025
Mint Mumbai
Telcos slam Trai penalty plan for financial report flaws
Trai has proposed turnover-linked penalties for filing incorrect, incomplete financial reports
2 mins
November 28, 2025
Mint Mumbai
Consumers warm up to Bolt as it aces 10-min hunger games
A year after launch, Bolt is emerging as Swiggy's fastest-scaling bet.
2 mins
November 28, 2025
Mint Mumbai
Doing India’s needy a good turn: Everyone is welcome to pitch in
What may seem weakly linked with positive outcomes on the ground could work wonders over time
3 mins
November 28, 2025
Mint Mumbai
GOING SOLO: FACING THE GROWING REALITY OF SOLITARY RETIREMENT IN INDIA
What we plan for ourselves isn't always what life plans for us.
2 mins
November 28, 2025
Mint Mumbai
Catamaran to boost manufacturing bets
Catamaran is focused on a few areas in manufacturing, such as aerospace
2 mins
November 28, 2025
Mint Mumbai
How the latest labour codes will benefit most employees
Workers may see an increase in some statutory benefits such as gratuity and leave encashment
4 mins
November 28, 2025
Mint Mumbai
Tune into weak signals in a world of data dominance
World War II saw the full fury of air power in battle, first exercised by Axis forces and then by the Allies, culminating in American B-29 bombers dropping atomic bombs on Hiroshima and Nagasaki.
4 mins
November 28, 2025
Mint Mumbai
Investors expect AI use to soar. That's not happening
An uncertain outlook for interest rates. Businesses may be holding off on investment until the fog clears. In addition, history suggests that technology tends to spread in fits and starts. Consider use of the computer within American households, where the speed of adoption slowed in the late 1980s. This was a mere blip before the 1990s, when they invaded American homes.
2 mins
November 28, 2025
Mint Mumbai
Tech startups on M&A route to boost scale, market share
M&As were earlier used to enter new markets or geographies, but that strategy has evolved
2 mins
November 28, 2025
Listen
Translate
Change font size